|
KIAA0247 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.3200000000061E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.971600E-04 |
| Normal-vs-Stage2 |
2.629900E-02 |
| Normal-vs-Stage3 |
3.233700E-04 |
| Normal-vs-Stage4 |
6.23260000000014E-05 |
| Stage1-vs-Stage2 |
8.161200E-01 |
| Stage1-vs-Stage3 |
3.324400E-01 |
| Stage1-vs-Stage4 |
1.128010E-01 |
| Stage2-vs-Stage3 |
3.277000E-01 |
| Stage2-vs-Stage4 |
6.688400E-02 |
| Stage3-vs-Stage4 |
1.978960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.570800E-04 |
| Normal-vs-AfricanAmerican |
3.998200E-04 |
| Normal-vs-Asian |
1.249550E-04 |
| Caucasian-vs-AfricanAmerican |
4.775600E-01 |
| Caucasian-vs-Asian |
1.598960E-01 |
| AfricanAmerican-vs-Asian |
1.124380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.27499999999803E-05 |
| Normal-vs-Female |
1.544150E-02 |
| Male-vs-Female |
4.998200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.970400E-04 |
| Normal-vs-Extreme_Weight |
6.45950000000006E-05 |
| Normal-vs-Obese |
7.819900E-02 |
| Normal-vs-Extreme_Obese |
2.096400E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.641200E-01 |
| Normal_Weight-vs-Obese |
8.542200E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.172800E-01 |
| Extreme_Weight-vs-Obese |
9.324000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.769600E-01 |
| Obese-vs-Extreme_Obese |
5.727800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.023600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.804480E-02 |
| Normal-vs-Age(61-80Yrs) |
1.41200000003394E-06 |
| Normal-vs-Age(81-100Yrs) |
3.940300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.894600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.601600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.459000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.116360E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.641800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.944800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.598270E-04 |
| Normal-VS-Type2 PRCC |
9.176800E-04 |
| Normal-VS-KIRP CIMP |
1.215500E-04 |
| Normal-VS-Unclassified PRCC |
2.808600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.989000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.496550E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.357590E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.318000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.641200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.016200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.74050000000459E-05 |
| Normal-vs-N1 |
3.981500E-04 |
| Normal-vs-N2 |
1.302400E-03 |
| N0-vs-N1 |
5.497600E-01 |
| N0-vs-N2 |
3.464200E-01 |
| N1-vs-N2 |
5.925800E-01 |
|
|
